+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leadless Pacemakers Market Size, Share & Trends Analysis Report By Pacing Chamber (Single Chamber, Dual Chamber), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899652
The global leadless pacemakers market size is anticipated to reach USD 1.74 billion by 2030. The market is projected to grow at a CAGR of 15.7% from 2023 to 2030. The growth of the market is attributed to technological advancements, rising prevalence of heart diseases, and preference for minimally invasive procedures. Moreover, the growing aging population globally propels the demand for leadless pacemakers, as bradycardia is common in the geriatric population. According to the Cleveland Clinic, approximately half a million of the geriatric population show symptoms of bradycardia, thereby driving the growth in the leadless pacemakers industry.

Wireless or leadless pacemakers, frequently used in adult patients, have emerged as a potentially safe and efficient temporary alternative for children experiencing bradycardia, as revealed by research featured in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal affiliated with the American Heart Association. This development is expected to be a potential driver for the growth of the market.

In addition, growing business initiatives by the companies for leadless pacemakers propels the industry growth. In July 2021, MicroPort Scientific Corporation concluded definitive agreements related to its Series C financing round. The financing has successfully garnered a total investment of USD 150 million. Moreover, one of the key objectives of this funding is to develop and commercialize its leadless pacemakers by 2027 - 2028.

Leadless Pacemakers Market Report Highlights

  • In terms of region, North America dominated the market in 2022 with a revenue share of 50.71%. This growth can be attributed to the increasing number of heart patients, growing product approvals from federal regulatory bodies, technological advancements, and ease of accessibility of the procedure
  • In terms of pacing chamber, the single chamber segment dominated the market in 2022 with a revenue share of 67.40%. Single-chamber leadless pacemakers are suitable for a broader range of patients with bradycardia or heart block.
  • In terms of end-use, the hospitals segment dominated the market in 2022 with a revenue share of 89.0%. This share is attributed to the availability of advanced infrastructure, collaborations and partnerships, and clinical trials


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Volume Price Analysis
1.5.1.1. Approach 1: Volume Price Analysis
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Leadless Pacemakers Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Rising prevalence of cardiovascular diseases
3.3.1.2. Favorable reimbursement policies
3.3.1.3. Growing adoption of leadless pacemaker instead of traditional pacemaker due to clinical safety.
3.3.2. Market restraint analysis
3.3.2.1. Limited manufacturers in the marketplace
3.4. Business Environment Analysis
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.2. Porter’s Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Leadless Pacemakers Market: Pacing Chamber Business Analysis
4.1. Leadless Pacemakers Market: Pacing Chambers Movement & Market Share Analysis, 2022 & 2030
4.2. Single Chamber
4.2.1. Single Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3. Dual Chamber
4.3.1. Dual Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Leadless Pacemakers Market: End-use Business Analysis
5.1. Leadless Pacemakers Market: End-use Movement & Market Share Analysis, 2022 & 2030
5.2. Hospitals
5.2.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Outpatient Facilities
5.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Leadless Pacemakers Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.2. Market Share Analysis by Country, 2022
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. MEA
6.3. North America
6.3.1. North America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.3. Canada
6.3.3.1. Canada Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.4. Europe
6.4.1. Europe Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Germany Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.3. UK
6.4.3.1. UK Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.4. France
6.4.4.1. France Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.5. Italy
6.4.5.1. Italy Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.6. Spain
6.4.6.1. Spain Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.7. Denmark
6.4.7.1. Denmark Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.8. Sweden
6.4.8.1. Sweden Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.8.2. Key Country Dynamics
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.9. Norway
6.4.9.1. Norway Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.4.9.2. Key Country Dynamics
6.4.9.3. Competitive Scenario
6.4.9.4. Regulatory Framework
6.5. Asia Pacific
6.5.1. Asia Pacific Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Japan Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.3. China
6.5.3.1. China Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.4. India
6.5.4.1. India Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.4.2. Key Country Dynamics
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.5. South Korea
6.5.5.1. South Korea Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.5.2. Key Country Dynamics
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.6. Australia
6.5.6.1. Australia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.6.2. Key Country Dynamics
6.5.6.3. Competitive Scenario
6.5.6.4. Regulatory Framework
6.5.7. Thailand
6.5.7.1. Thailand Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.5.7.2. Key Country Dynamics
6.5.7.3. Competitive Scenario
6.5.7.4. Regulatory Framework
6.6. Latin America
6.6.1. Latin America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.3. Mexico
6.6.3.1. Mexico Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.4. Argentina
6.6.4.1. Argentina Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.7. MEA
6.7.1. MEA Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. South Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.7.2.2. Key Country Dynamics
6.7.2.3. Competitive Scenario
6.7.2.4. Regulatory Framework
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.7.3.2. Key Country Dynamics
6.7.3.3. Competitive Scenario
6.7.3.4. Regulatory Framework
6.7.4. UAE
6.7.4.1. UAE Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.7.4.2. Key Country Dynamics
6.7.4.3. Competitive Scenario
6.7.4.4. Regulatory Framework
6.7.5. Kuwait
6.7.5.1. Kuwait Leadless Pacemakers Market, 2018 - 2030 (USD Million)
6.7.5.2. Key Country Dynamics
6.7.5.3. Competitive Scenario
6.7.5.4. Regulatory Framework
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Profiles/Listing
7.3.1. Abbott
7.3.1.1. Overview
7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.1.3. Product Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Medtronic
7.3.2.1. Overview
7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.2.3. Product Benchmarking
7.3.2.4. Strategic Initiatives
List of Tables
Table 1. List of Abbreviations
Table 2. List of Secondary Sources
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Leadless pacemakers market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Leadless Pacemakers Market: Pacing Chamber Outlook Key Takeaways
Fig. 15 Leadless Pacemakers Market: Pacing Chamber Movement Analysis
Fig. 16 Single Chamber Market Estimates and Forecast, 2018-2030 (USD Million)
Fig. 17 Dual Chamber Market Estimates and Forecast, 2018-2030 (USD Million)
Fig. 18 Leadless Pacemakers Market: End-use Outlook Key Takeaways
Fig. 19 Leadless Pacemakers Market: End-use Movement Analysis
Fig. 20 Hospitals Market Estimates and Forecast, 2018-2030 (USD Million)
Fig. 21 Outpatient Facilities Market Estimates and Forecast Market, 2018-2030 (USD Million)
Fig. 22 Regional Marketplace: Key Takeaways
Fig. 23 Regional outlook, 2022 & 2030
Fig. 24 Global Leadless Pacemakers Market: Region Movement Analysis
Fig. 25 North America Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 26 U.S. Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 27 Canada Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 28 Europe Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 29 Germany Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 30 UK Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 31 France Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 32 Italy Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 33 Spain Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 34 Denmark Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 35 Sweden Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 36 Norway Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 37 Asia Pacific Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 38 Japan Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 39 China Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 40 India Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 41 Australia Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 42 South Korea Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 43 Thailand Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 44 Latin America Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 45 Brazil Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 46 Mexico Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 47 Argentina Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 48 Middle East and Africa Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 49 South Africa Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 50 Saudi Arabia Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 51 Kuwait Leadless Pacemakers Market, 2018-2030 (USD Million)
Fig. 52 UAE Leadless Pacemakers Market, 2018-2030 (USD Million)

Companies Mentioned

  • Abbott
  • Medtronic

Methodology

Loading
LOADING...

Table Information